These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36603985)

  • 1. Challenges and opportunities in interventions for chronic kidney disease of unknown origin (CKDu): report from the International Society of Nephrology Consortium of Collaborators on CKDu.
    Smyth B; Glaser J; Butler-Dawson J; Nanayakkara N; Wegman DH; Anand S; Levin A;
    Kidney Int; 2023 Jan; 103(1):6-12. PubMed ID: 36603985
    [No Abstract]   [Full Text] [Related]  

  • 2. Kidney biopsies among persons living in hotspots of CKDu: a position statement from the International Society of Nephrology's Consortium of Collaborators on CKDu.
    Wijewickrama E; Behera S; Garcia P; Avila-Casado C; Caplin B; Paolo VS; Courville K; Friedman D; Madero M; Jha V; Kambham N; Levin A; Anand S;
    Kidney Int; 2024 Mar; 105(3):464-469. PubMed ID: 38160755
    [No Abstract]   [Full Text] [Related]  

  • 3. The International Society of Nephrology's International Consortium of Collaborators on Chronic Kidney Disease of Unknown Etiology: report of the working group on approaches to population-level detection strategies and recommendations for a minimum dataset.
    Caplin B; Yang CW; Anand S; Levin A; Madero M; Saran R; Jayasinghe S; De Broe M; Yeates K; Tonelli M; Jakobsson K; Strani L; Ruggiero A; Glaser J; Martin E; Pearce N; Wijewickrama E;
    Kidney Int; 2019 Jan; 95(1):4-10. PubMed ID: 30606428
    [No Abstract]   [Full Text] [Related]  

  • 4. AJKD Atlas of Renal Pathology: CKD of Unknown Cause (CKDu); Mesoamerican Nephropathy.
    Lusco MA; Fogo AB; Wernerson AÖ; Najafian B; Alpers CE
    Am J Kidney Dis; 2017 Sep; 70(3):e17-e18. PubMed ID: 28842062
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiology, molecular, and genetic methodologies to evaluate causes of CKDu around the world: report of the Working Group from the ISN International Consortium of Collaborators on CKDu.
    Anand S; Caplin B; Gonzalez-Quiroz M; Schensul SL; Bhalla V; Parada X; Nanayakkara N; Fire A; Levin A; Friedman DJ;
    Kidney Int; 2019 Dec; 96(6):1254-1260. PubMed ID: 31759481
    [No Abstract]   [Full Text] [Related]  

  • 6. CKD Hotspots: Challenges and Areas of Opportunity.
    Obrador GT; Levin A
    Semin Nephrol; 2019 May; 39(3):308-314. PubMed ID: 31054631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early renal damage among children living in the region of highest burden of chronic kidney disease of unknown etiology (CKDu) in Sri Lanka.
    Agampodi SB; Amarasinghe GS; Naotunna PGCR; Jayasumana CS; Siribaddana SH
    BMC Nephrol; 2018 May; 19(1):115. PubMed ID: 29769043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence, prevalence and trends of Chronic Kidney Disease and Chronic Kidney Disease of uncertain aetiology (CKDu) in the North Central Province of Sri Lanka: an analysis of 30,566 patients.
    Ranasinghe AV; Kumara GWGP; Karunarathna RH; De Silva AP; Sachintani KGD; Gunawardena JMCN; Kumari SKCR; Sarjana MSF; Chandraguptha JS; De Silva MVC
    BMC Nephrol; 2019 Aug; 20(1):338. PubMed ID: 31462219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrology in the Eastern and Central European region: challenges and opportunities.
    Spasovski G; Rroji M; Vazelov E; Basic Jukic N; Tesar V; Mugosa Ratkovic M; Covic A; Naumovic R; Resic H; Turan Kazancioglu R
    Kidney Int; 2019 Aug; 96(2):287-290. PubMed ID: 31200943
    [No Abstract]   [Full Text] [Related]  

  • 10. Diminished disease progression rate in a chronic kidney disease population following the replacement of dietary water source with quality drinking water: A pilot study.
    Siriwardhana EARIE; Perera PAJ; Sivakanesan R; Abeysekara T; Nugegoda DB; Weerakoon K; Siriwardhana DAS
    Nephrology (Carlton); 2018 May; 23(5):430-437. PubMed ID: 28370958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beginning of a journey: unraveling the mystery of chronic kidney disease of unknown aetiology (CKDu) in Sri Lanka.
    Kumaresan J; Seneviratne R
    Global Health; 2017 Jun; 13(1):43. PubMed ID: 28666453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential diagnostic biomarkers for chronic kidney disease of unknown etiology (CKDu) in Sri Lanka: a pilot study.
    Sayanthooran S; Magana-Arachchi DN; Gunerathne L; Abeysekera T
    BMC Nephrol; 2017 Jan; 18(1):31. PubMed ID: 28103909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status, challenges, and the role of ISN in advancement of nephrology in the Newly Independent States and Russia region.
    Tchokhonelidze I; Zemchenkov A
    Kidney Int; 2019 Jul; 96(1):48-51. PubMed ID: 30819556
    [No Abstract]   [Full Text] [Related]  

  • 14. Snap shot view on anaemia in chronic kidney disease of uncertain aetiology.
    Fernando WBNT; Hettiarachchi TW; Sudeshika T; Badurdeen Z; Abeysundara H; Ranasinghe S; Rathnayake MP; Nanayakkara N
    Nephrology (Carlton); 2019 Oct; 24(10):1033-1040. PubMed ID: 30525261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Availability and prioritisation of COVID-19 vaccines among patients with advanced chronic kidney disease and kidney failure during the height of the pandemic: a global survey by the International Society of Nephrology.
    Wijewickrama ES; Abdul Hafidz MI; Robinson BM; Johnson DW; Liew A; Dreyer G; Caskey FJ; Bello AK; Zaidi D; Damster S; Salaro S; Luyckx VA; Bajpai D
    BMJ Open; 2022 Dec; 12(12):e065112. PubMed ID: 36585149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide survey of the coronavirus disease 2019 prevention and treatment systems for kidney disease patients: a study of Japanese Society of Nephrology-certified educational facilities.
    Sugawara Y; Iwagami M; Yoshida Y; Kikuchi K; Ando R; Shinoda T; Ryuzaki M; Nakamoto H; Sakai K; Hanafusa N; Kashihara N; Nangaku M; ; ;
    Clin Exp Nephrol; 2021 Sep; 25(9):996-1002. PubMed ID: 34057613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease of unknown etiology in Sri Lanka.
    Rajapakse S; Shivanthan MC; Selvarajah M
    Int J Occup Environ Health; 2016 Jul; 22(3):259-264. PubMed ID: 27399161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptospirosis Renal Disease: Emerging Culprit of Chronic Kidney Disease Unknown Etiology.
    Yang CW
    Nephron; 2018; 138(2):129-136. PubMed ID: 28926845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary Biomarkers KIM-1 and NGAL for Detection of Chronic Kidney Disease of Uncertain Etiology (CKDu) among Agricultural Communities in Sri Lanka.
    De Silva PM; Mohammed Abdul KS; Eakanayake EM; Jayasinghe SS; Jayasumana C; Asanthi HB; Perera HS; Chaminda GG; Chandana EP; Siribaddana SH
    PLoS Negl Trop Dis; 2016 Sep; 10(9):e0004979. PubMed ID: 27643785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative and quantitative dermatoglyphics of chronic kidney disease of unknown origin (CKDu) in Sri Lanka.
    Wijerathne BTB; Meier RJ; Salgado SS; Agampodi SB
    J Physiol Anthropol; 2020 Jan; 39(1):1. PubMed ID: 31952553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.